News

10/07/2025

IR Sant Pau Leads New Clinical Trial to Optimize Antibiotic Treatment for Complicated Pediatric Appendicitis

The Sant Pau Research Institute (IR Sant Pau) is leading the new multicenter clinical trial FTAA (Fast Track in Acute Appendicitis), aimed at improving the postoperative management of complicated appe...

09/07/2025

The Combination of Simvastatin and Rifaximin Offers No Clinical Benefits for Patients With Decompensated Cirrhosis

The CIBEREHD group from the Digestive Diseases Department at Hospital de Sant Pau has participated in an international clinical trial recently published in JAMA (Journal of the American Medical Associ...

08/07/2025

Sant Pau Receives Best Oral Presentation Award at SENEC 2025 for Pioneering Study on Neuromodulation in Parkinson’s Disease

The Neuromodulation in Movement Disorders Group at Hospital de Sant Pau has received the Best Oral Presentation Award at the 2025 Congress of the Spanish Society of Neurosurgery (SENEC), recently held...

07/07/2025

A New Blood Biomarker Predicts the Progression of Alzheimer’s Disease Even in Its Earliest Stages

A team of researchers at the Sant Pau Research Institute (IR Sant Pau) has demonstrated that the plasma biomarker p-tau217, obtained through a simple blood test, can predict the clinical progression o...

03/07/2025

Dr. Oriol Dols-Icardo Leads a Scientific Commentary on Genetic Advances in Frontotemporal Dementia

The prestigious journal Trends in Neurosciences recently published a scientific commentary authored by Dr. Oriol Dols-Icardo, a researcher with the Neurobiology of Dementias group at the Sant Pau Rese...